芬诺驱动器:用于研究乳腺癌中个性化表型相关驱动基因的可解释框架
Yan Li1, Shao-Wu Zhang1,2, Ming-Yu Xie1
1School of Automation from Northwestern Polytechnical University, China.
Briefings in bioinformatics
|September 22, 2023
概括
芬诺驱动器识别了个性化的癌症驱动基因及其机制,改善了对乳腺癌的理解和治疗. 这一框架揭示了基因在癌症发展中的作用,并将它们与临床变化联系起来.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 识别个性化癌症驱动基因对于理解细胞转化和临床诊断至关重要.
- 现有的方法往往侧重于队列或个人层面的基因鉴定,但缺乏机制阐明.
- 在将驱动基因与其特定的致癌作用和临床表型变化的联系方面存在差距.
研究的目的:
- 介绍PhenoDriver,这是个性化癌症驱动基因识别的可解释框架.
- 阐明已识别的驱动基因的致癌机制及其与临床表型的关联.
- 发现新的乳腺癌亚型及其潜在的分子机制.
主要方法:
- 开发并应用了PhenoDriver框架来分析988名乳腺癌患者的基因组数据.
- 对PhenoDriver的性能进行了评估,并与用于队列级驱动基因识别的最新方法进行了比较.
- 利用PhenoDriver识别个体患者中复发性和罕见的驱动突变,并构建基因子网络.
主要成果:
- 芬诺驱动器在确定队列水平的乳腺癌驱动基因方面表现出卓越的表现.
- 该框架有效地识别了个性化的驱动基因,包括那些具有罕见突变的基因.
- 研究已知和新型驱动基因 (例如TP53,MAP3K1,HTT) 的致癌机制及其相关子网络.
- 发现了两种已知的乳腺癌亚型和一种具有阐明分子机制的新型乳腺癌亚型.
结论:
- 芬诺驱动器为个性化癌症驱动基因识别和机制发现提供了一种强大的方法.
- 这些发现提高了对乳腺癌机制的理解,并为治疗决策提供了洞察力.
- 该框架通过揭示个性化的驾驶员配置文件和亚型,有助于开发有针对性的抗癌疗法.
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


